ICMR has collected over Rs 171 crores as royalty from Covaxin’s sales: Government
The ICMR has spent around Rs 35 crores in research and development of Covaxin
The Indian Council of Medical Research (ICMR) has received a royalty of Rs 171.74 crores till 31st January from Bharat Biotech from sales of Covaxin, Rajya Sabha was told yesterday.
The ICMR has spent around Rs 35 crores in research and development of Covaxin.
Funds with ICMR are utilised for health research activities including emerging research priorities and research capacity building, Bharati Pravin Pawar, Minister of State for Health, said in a written reply.
She was responding to a question on the total money collected by ICMR as royalty from sales of Bharat Biotech’s Covaxin and how much of the initial cost of ICMR in doing R&D for the development of Covaxin has been recovered from the amount collected so far.